Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more ...
Delayed onset of canonical babbling and first words is often reported in infants later diagnosed with autism spectrum disorder (ASD). Identifying the neural mechanisms underlying language acquisition ...
Hopper Throttle MaxStax Soybean advanced planter box treatment copack on naked soybeans topped liquid seed treatment in the ...
While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...
TipRanks on MSN
Regeneron advances phase 3 antibody trial in birch pollen eye allergy: What investors should know
Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Study OverviewRegeneron Pharmaceuticals has launched a new ...
A new study suggests that a moderate dose of psilocybin can effectively reduce symptoms of obsessive-compulsive disorder for ...
Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...
Agenus Inc. , a leader in immuno-oncology innovation, today announced the publication of clinical results from the ovarian cancer cohort of its Phase 1b C-800-01 trial evaluating botensilimab plus ...
Conclusions: Two-stage HRSN screening based on geography is suboptimal. Although a 2-stage approach based on area-level socioeconomic measures can reduce the number of patients requiring ...
An intervention to increase point-of-care ultrasound-guided regional anesthesia (POCUS-GRA) uptake by emergency physicians was safe, effective, and significantly reduced the odds of delirium. Evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback